Advertisement

Index by author

November 01, 1995; Volume 48,Issue 5

A

  1. Abraham, D G

    1. Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
      D G Abraham, R J Thomas and A J Cooper
      Molecular Pharmacology November 1995, 48 (5) 855-860;

  2. Allan, W P

    1. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
      M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
      Molecular Pharmacology November 1995, 48 (5) 798-805;

B

  1. Benjamin, C W

    1. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
      D A Jones, C W Benjamin and D A Linseman
      Molecular Pharmacology November 1995, 48 (5) 890-896;

  2. Betz, H

    1. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
      V Schmieden and H Betz
      Molecular Pharmacology November 1995, 48 (5) 919-927;

  3. Boundy, V A

    1. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
      V A Boundy, M A Pacheco, W Guan and P B Molinoff
      Molecular Pharmacology November 1995, 48 (5) 956-964;

C

  1. Chaudhary, A

    1. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
      T H Johansen, A Chaudhary and T A Verdoorn
      Molecular Pharmacology November 1995, 48 (5) 946-955;

  2. Chen, J

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

  3. Colell, A

    1. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
      C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
      Molecular Pharmacology November 1995, 48 (5) 825-834;

  4. Cooper, A J

    1. Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
      D G Abraham, R J Thomas and A J Cooper
      Molecular Pharmacology November 1995, 48 (5) 855-860;

  5. Crooke, S T

    1. Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
      D Hodges and S T Crooke
      Molecular Pharmacology November 1995, 48 (5) 905-918;

D

  1. Dahlman-Wright, K

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

  2. de Bont, H J

    1. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
      B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke
      Molecular Pharmacology November 1995, 48 (5) 928-937;

  3. Devaud, L L

    1. Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
      L L Devaud, F D Smith, D R Grayson and A L Morrow
      Molecular Pharmacology November 1995, 48 (5) 861-868;

F

  1. Fernández-Checa, J C

    1. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
      C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
      Molecular Pharmacology November 1995, 48 (5) 825-834;

  2. ffrench-Constant, R H

    1. Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
      H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
      Molecular Pharmacology November 1995, 48 (5) 835-840;

  3. Fields, A P

    1. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
      M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
      Molecular Pharmacology November 1995, 48 (5) 798-805;

  4. Freissmuth, M

    1. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
      C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
      Molecular Pharmacology November 1995, 48 (5) 806-817;

G

  1. García-Ruiz, C

    1. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
      C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
      Molecular Pharmacology November 1995, 48 (5) 825-834;

  2. Goudreau, N

    1. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
      A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
      Molecular Pharmacology November 1995, 48 (5) 783-789;

  3. Grayson, D R

    1. Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
      L L Devaud, F D Smith, D R Grayson and A L Morrow
      Molecular Pharmacology November 1995, 48 (5) 861-868;

  4. Guan, W

    1. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
      V A Boundy, M A Pacheco, W Guan and P B Molinoff
      Molecular Pharmacology November 1995, 48 (5) 956-964;

  5. Guillaume, N

    1. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
      A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
      Molecular Pharmacology November 1995, 48 (5) 783-789;

  6. Gustafsson, J A

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

H

  1. Hentosh, P

    1. In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate.
      P Hentosh and M Tibudan
      Molecular Pharmacology November 1995, 48 (5) 897-904;

  2. Hiroi, N

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

  3. Hodges, D

    1. Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
      D Hodges and S T Crooke
      Molecular Pharmacology November 1995, 48 (5) 905-918;

  4. Hohenegger, M

    1. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
      C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
      Molecular Pharmacology November 1995, 48 (5) 806-817;

  5. Holtmann, M H

    1. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
      F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
      Molecular Pharmacology November 1995, 48 (5) 818-824;

  6. Hope, B T

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

I

  1. Ichikawa, A

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

J

  1. Jackson, M B

    1. Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
      H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
      Molecular Pharmacology November 1995, 48 (5) 835-840;

  2. Jagerschmidt, A

    1. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
      A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
      Molecular Pharmacology November 1995, 48 (5) 783-789;

  3. Johansen, T H

    1. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
      T H Johansen, A Chaudhary and T A Verdoorn
      Molecular Pharmacology November 1995, 48 (5) 946-955;

  4. Jones, D A

    1. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
      D A Jones, C W Benjamin and D A Linseman
      Molecular Pharmacology November 1995, 48 (5) 890-896;

K

  1. Kaplowitz, N

    1. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
      C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
      Molecular Pharmacology November 1995, 48 (5) 825-834;

  2. Kelz, M B

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

  3. Kerby, J

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

  4. Kotani, M

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

L

  1. Laughton, P

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

  2. Le Bourdellés, B

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

  3. Lee, H J

    1. Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
      H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
      Molecular Pharmacology November 1995, 48 (5) 835-840;

  4. Linseman, D A

    1. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
      D A Jones, C W Benjamin and D A Linseman
      Molecular Pharmacology November 1995, 48 (5) 890-896;

M

  1. Maigret, B

    1. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
      A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
      Molecular Pharmacology November 1995, 48 (5) 783-789;

  2. Makino, I

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

  3. Makino, Y

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

  4. Miller, L J

    1. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
      F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
      Molecular Pharmacology November 1995, 48 (5) 818-824;

  5. Mitterauer, T

    1. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
      C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
      Molecular Pharmacology November 1995, 48 (5) 806-817;

  6. Molinoff, P B

    1. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
      V A Boundy, M A Pacheco, W Guan and P B Molinoff
      Molecular Pharmacology November 1995, 48 (5) 956-964;

  7. Morales, A

    1. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
      C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
      Molecular Pharmacology November 1995, 48 (5) 825-834;

  8. Mori, K

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

  9. Morrow, A L

    1. Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
      L L Devaud, F D Smith, D R Grayson and A L Morrow
      Molecular Pharmacology November 1995, 48 (5) 861-868;

  10. Murray, N R

    1. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
      M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
      Molecular Pharmacology November 1995, 48 (5) 798-805;

  11. Myers, J

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

N

  1. Nagelkerke, J F

    1. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
      B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke
      Molecular Pharmacology November 1995, 48 (5) 928-937;

  2. Nakabeppu, Y

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

  3. Nakao, K

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

  4. Nanoff, C

    1. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
      C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
      Molecular Pharmacology November 1995, 48 (5) 806-817;

  5. Narumiya, S

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

  6. Nestler, E J

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

  7. Nye, H E

    1. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
      J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
      Molecular Pharmacology November 1995, 48 (5) 880-889;

O

  1. Ogawa, Y

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

  2. Okamoto, K

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

  3. Ozcelebi, F

    1. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
      F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
      Molecular Pharmacology November 1995, 48 (5) 818-824;

P

  1. Pacheco, M A

    1. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
      V A Boundy, M A Pacheco, W Guan and P B Molinoff
      Molecular Pharmacology November 1995, 48 (5) 956-964;

  2. Pampori, N A

    1. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
      D J Waxman, P A Ram, N A Pampori and B H Shapiro
      Molecular Pharmacology November 1995, 48 (5) 790-797;

  3. Priestley, T

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

R

  1. Ram, P A

    1. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
      D J Waxman, P A Ram, N A Pampori and B H Shapiro
      Molecular Pharmacology November 1995, 48 (5) 790-797;

  2. Rao, R

    1. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
      F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
      Molecular Pharmacology November 1995, 48 (5) 818-824;

  3. Rentsch, R U

    1. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
      F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
      Molecular Pharmacology November 1995, 48 (5) 818-824;

  4. Ritke, M K

    1. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
      M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
      Molecular Pharmacology November 1995, 48 (5) 798-805;

  5. Rocheleau, T

    1. Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
      H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
      Molecular Pharmacology November 1995, 48 (5) 835-840;

  6. Roka, F

    1. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
      C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
      Molecular Pharmacology November 1995, 48 (5) 806-817;

  7. Roques, B P

    1. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
      A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
      Molecular Pharmacology November 1995, 48 (5) 783-789;

S

  1. Schmieden, V

    1. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
      V Schmieden and H Betz
      Molecular Pharmacology November 1995, 48 (5) 919-927;

  2. Shapiro, B H

    1. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
      D J Waxman, P A Ram, N A Pampori and B H Shapiro
      Molecular Pharmacology November 1995, 48 (5) 790-797;

  3. Smith, F D

    1. Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
      L L Devaud, F D Smith, D R Grayson and A L Morrow
      Molecular Pharmacology November 1995, 48 (5) 861-868;

T

  1. Tanaka, H

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

  2. Tanaka, I

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

  3. Thomas, R J

    1. Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
      D G Abraham, R J Thomas and A J Cooper
      Molecular Pharmacology November 1995, 48 (5) 855-860;

  4. Tibudan, M

    1. In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate.
      P Hentosh and M Tibudan
      Molecular Pharmacology November 1995, 48 (5) 897-904;

U

  1. Usui, T

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

V

  1. van de Water, B

    1. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
      B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke
      Molecular Pharmacology November 1995, 48 (5) 928-937;

  2. Verdoorn, T A

    1. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
      T H Johansen, A Chaudhary and T A Verdoorn
      Molecular Pharmacology November 1995, 48 (5) 946-955;

W

  1. Waxman, D J

    1. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
      D J Waxman, P A Ram, N A Pampori and B H Shapiro
      Molecular Pharmacology November 1995, 48 (5) 790-797;

  2. Whiting, P J

    1. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
      T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
      Molecular Pharmacology November 1995, 48 (5) 841-848;

  3. Wright KD [corrected to Dahlman-Wright, K ]

    1. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
      H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
      Molecular Pharmacology November 1995, 48 (5) 938-945;

Y

  1. Yagami, T

    1. Differential coupling of glucagon and beta-adrenergic receptors with the small and large forms of the stimulatory G protein.
      T Yagami
      Molecular Pharmacology November 1995, 48 (5) 849-854;

  2. Yalowich, J C

    1. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
      M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
      Molecular Pharmacology November 1995, 48 (5) 798-805;

  3. Yoshimi, T

    1. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
      M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
      Molecular Pharmacology November 1995, 48 (5) 869-879;

Z

  1. Zhang, H G

    1. Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
      H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
      Molecular Pharmacology November 1995, 48 (5) 835-840;

  2. Zoeteweij, J P

    1. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
      B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke
      Molecular Pharmacology November 1995, 48 (5) 928-937;
Back to top

In this issue

Advertisement